Active Ingredient: Budesonide+Formoterol
Asthma: Treatment of asthma in patients ≥6 years.
Chronic obstructive pulmonary disease: Maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema; to reduce COPD exacerbations.
Limitations of use: Budesonide/formoterol is not indicated for the relief of acute bronchospasm.